Switching from an originator biologic to a biosimilar is safe for most patients, with strong evidence showing equal effectiveness and safety. Cost savings are significant, but patient education and careful monitoring are key to success.
full article
The Orange Book database from the FDA lists approved prescription drugs, their patents, and therapeutic equivalence ratings - enabling generic competition and saving billions in healthcare costs.
full article
Tyramine-rich foods can trigger dangerous blood pressure spikes in people taking MAO inhibitors. Learn which foods to avoid, how different MAOIs affect risk, and what to do if symptoms appear.
full article
Discover how to find the lowest prices for generic medications using real-time tools, apps, and state-level programs. Learn why prices vary, how to use coupons wisely, and what's changing in 2025.
full article
Medication-induced acute interstitial nephritis is a hidden cause of kidney damage, often mistaken for other conditions. Learn the key signs, which drugs trigger it, and what to do before permanent damage occurs.
full article
Patent exclusivity and market exclusivity are two different systems that protect new drugs in the U.S. One comes from the patent office, the other from the FDA. Understanding how they work explains why some drugs stay expensive long after patents expire.
full article
Pediatric safety networks bring together hospitals and states to track side effects in children more effectively than traditional trials. They’ve changed how we understand drug safety and injury prevention for kids.
full article
Heart failure management has evolved dramatically. From early-stage prevention to advanced therapies like SGLT2 inhibitors and implantable monitors, today's guidelines offer real hope. Learn how to navigate diagnosis, treatment, and daily living with evidence-based strategies.
full article
Authorized generics offer the same medication as brand-name drugs at lower prices, with no formulation changes - making them a safer, more reliable option for patients switching from brand-name prescriptions.
full article
SNRI medications like venlafaxine and duloxetine treat depression and chronic pain by targeting serotonin and norepinephrine. Learn about their side effects, how they compare, and what to expect when starting or stopping them.
full article
